Making Clinical Genomics a Reality – Trans Atlantic Challenges and Examples

In Partnership with Canada House

With the rapid developments in genome sequencing technologies and the characterisation of expressed human genes, has emerged great possibilities in better diagnostics, patient stratification, even therapeutics for a range of untreated conditions.  

The R&D community in genomics, diagnostics and pharma are making tremendous progress towards the potential for the delivery of clinical genomics. However this is not coming without the challenges of adapting existing regulatory, reimbursement and care pathways.   

Many countries are now facing the big challenge that is adopting clinical genomics as a standard of care not only for their population health benefits, but also to maintain their attractiveness to these cutting edge R&D companies. 

This event will review some examples of national or regional initiatives facilitating genomics research and adoption in healthcare delivery. It will also discuss the challenges they have in common and potential solutions that can be shared. 

Programme

13:00 - Welcome Coffee and Registration

13:30 - Welcome from the Canadian High Commission and One Nucleus

13:40 - Part One – Overcoming Challenges
Chair:
Tony Jones, One Nucleus

13.40 – Transforming Innovation in Genomics: Illumina Accelerator
Crystal Ruff, Illumina

14.00 – How We Are Transforming the Lives of Cancer Patients with the Power of Liquid Biopsy 
Clive Morris, Inivata

14.20 –  Building Solutions to Advance Genomic Medicine with Blockchain Technology
Natalie Pankova, Shivom

14.40 – Beyond Genomics: Using a Diverse Range of Bio-Markers to Predict Health and Disease Risk
Pieter Cullis, Molecular You

15:00 - Coffee Break

15:30 - Part Two – Examples of National and Regional Initiatives
Chair:
Tony Jones, One Nucleus

15:30 – Leading the Healthcare Revolution Using Clinical and Genomic Data
Joanne Hackett, Genomics England

15:50 – Advances in Clinical Genomics in Québec
Daniel Tessier, Genome Quebec

16:10 – Personalised Medicine: The Role of European Research Infrastructures
Gary Saunders, ELIXIR

16.30 – Democratising Healthcare Through Genomics to Positively Disrupt Outcomes for Everyone. Why Diversity Matters 
Paul Matthews, Global Gene Corp

16.50 – Closing Remarks

17:00 - Close

There will be a free Labiotech Refresh event taking place following this meeting, which will finish with a networking reception.  Please see the link for more information https://bit.ly/2PrOlg2. 

Please note for security at this event you are required to bring Photo ID.  Also, please be aware suitcases are not allowed into the building and any electronic devices larger than a mobile will need to go into lockers.  Please contact us if you have any queries.